Adapting to new HIV testing realities in the post-pandemic world
Moderators
Christa CHEN
Abbott, Singapore
Natasha PHILLIPS
Abbott, United States
Organizer
Share
Achievement of the UNIAIDS 95:95:95 targets by country are in danger due to significant variability in progress across populations and countries. With lost time from the pandemic, how can health systems leverage on existing resources and capabilities to better coordinate their efforts to optimize the clinical cascade and achieve their goals by 2030? Join our global panel to discuss their experiences and learn from these countries’ best practices
07:30
5 min
Introduction
Abbott, Singapore
07:35
15 min
The role of molecular labs in HIV management
Uganda National Health Laboratory and Diagnostic Serves, Uganda
07:50
15 min
Expanding HIV testing programs for co-infections
Chulalongkorn University, Thailand
08:05
10 min
Opportunistic HPV testing for women living with HIV
Abbott Laboratories (S) Pte Ltd, Singapore
08:15
15 min
Q&A and panel discussion
Abbott, Singapore
Chulalongkorn University, Thailand
Abbott, United States
Uganda National Health Laboratory and Diagnostic Serves, Uganda
Abbott Laboratories (S) Pte Ltd, Singapore